DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.19 Billion USD | 28.71% |
| 2022 | 3.25 Billion USD | 24.8% |
| 2021 | 2.61 Billion USD | 6.01% |
| 2020 | 2.46 Billion USD | 62.92% |
| 2019 | 1.51 Billion USD | 20.73% |
| 2018 | 1.25 Billion USD | 158.45% |
| 2017 | 484.7 Million USD | 307.31% |
| 2016 | 119 Million USD | 68.08% |
| 2015 | 70.8 Million USD | 59.46% |
| 2014 | 44.4 Million USD | 15.63% |
| 2013 | 38.4 Million USD | 32.41% |
| 2012 | 29 Million USD | 81.42% |
| 2011 | 15.98 Million USD | -1.15% |
| 2010 | 16.17 Million USD | -75.27% |
| 2009 | 65.39 Million USD | -21.19% |
| 2008 | 82.97 Million USD | 18.3% |
| 2007 | 70.14 Million USD | 808.09% |
| 2006 | 7.72 Million USD | 5.61% |
| 2005 | 7.31 Million USD | -90.7% |
| 2004 | 78.66 Million USD | 47.41% |
| 2003 | 53.36 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 4.37 Billion USD | 0.23% |
| 2024 Q1 | 4.23 Billion USD | 0.94% |
| 2024 Q2 | 4.36 Billion USD | 3.06% |
| 2023 FY | 4.19 Billion USD | 28.71% |
| 2023 Q4 | 4.19 Billion USD | -3.06% |
| 2023 Q2 | 4.72 Billion USD | 43.78% |
| 2023 Q1 | 3.28 Billion USD | 0.71% |
| 2023 Q3 | 4.32 Billion USD | -8.3% |
| 2022 Q1 | 2.86 Billion USD | 9.79% |
| 2022 FY | 3.25 Billion USD | 24.8% |
| 2022 Q2 | 2.96 Billion USD | 3.27% |
| 2022 Q3 | 3.07 Billion USD | 3.82% |
| 2022 Q4 | 3.25 Billion USD | 6.02% |
| 2021 Q1 | 2.48 Billion USD | 0.92% |
| 2021 Q2 | 2.5 Billion USD | 0.79% |
| 2021 Q3 | 2.63 Billion USD | 5.33% |
| 2021 Q4 | 2.61 Billion USD | -1.05% |
| 2021 FY | 2.61 Billion USD | 6.01% |
| 2020 Q3 | 2.33 Billion USD | 7.66% |
| 2020 Q1 | 1.51 Billion USD | 0.07% |
| 2020 Q2 | 2.16 Billion USD | 43.25% |
| 2020 Q4 | 2.46 Billion USD | 5.57% |
| 2020 FY | 2.46 Billion USD | 62.92% |
| 2019 FY | 1.51 Billion USD | 20.73% |
| 2019 Q4 | 1.51 Billion USD | 6.4% |
| 2019 Q3 | 1.42 Billion USD | 3.18% |
| 2019 Q2 | 1.37 Billion USD | 5.53% |
| 2019 Q1 | 1.3 Billion USD | 4.21% |
| 2018 Q1 | 475.1 Million USD | -1.98% |
| 2018 Q3 | 552.1 Million USD | 5.08% |
| 2018 Q4 | 1.25 Billion USD | 126.9% |
| 2018 FY | 1.25 Billion USD | 158.45% |
| 2018 Q2 | 525.4 Million USD | 10.59% |
| 2017 Q2 | 441.9 Million USD | 133.32% |
| 2017 Q4 | 484.7 Million USD | 5.62% |
| 2017 FY | 484.7 Million USD | 307.31% |
| 2017 Q1 | 189.4 Million USD | 59.16% |
| 2017 Q3 | 458.9 Million USD | 3.85% |
| 2016 Q4 | 119 Million USD | 18.88% |
| 2016 FY | 119 Million USD | 68.08% |
| 2016 Q3 | 100.1 Million USD | 15.86% |
| 2016 Q2 | 86.4 Million USD | 26.69% |
| 2016 Q1 | 68.2 Million USD | -3.67% |
| 2015 Q2 | 47.7 Million USD | 17.2% |
| 2015 Q3 | 63.4 Million USD | 32.91% |
| 2015 Q4 | 70.8 Million USD | 11.67% |
| 2015 FY | 70.8 Million USD | 59.46% |
| 2015 Q1 | 40.7 Million USD | -8.33% |
| 2014 FY | 44.4 Million USD | 15.63% |
| 2014 Q2 | 40.1 Million USD | 14.9% |
| 2014 Q3 | 44.4 Million USD | 10.72% |
| 2014 Q4 | 44.4 Million USD | 0.0% |
| 2014 Q1 | 34.9 Million USD | -9.11% |
| 2013 Q4 | 38.4 Million USD | 8.47% |
| 2013 Q3 | 35.4 Million USD | 18.0% |
| 2013 FY | 38.4 Million USD | 32.41% |
| 2013 Q2 | 30 Million USD | 19.05% |
| 2013 Q1 | 25.2 Million USD | -13.1% |
| 2012 Q3 | 22.54 Million USD | 17.33% |
| 2012 Q4 | 29 Million USD | 28.64% |
| 2012 Q2 | 19.21 Million USD | 4.36% |
| 2012 Q1 | 18.41 Million USD | 15.18% |
| 2012 FY | 29 Million USD | 81.42% |
| 2011 Q1 | 13.19 Million USD | -18.42% |
| 2011 Q3 | 15.72 Million USD | 6.31% |
| 2011 Q4 | 15.98 Million USD | 1.63% |
| 2011 FY | 15.98 Million USD | -1.15% |
| 2011 Q2 | 14.79 Million USD | 12.14% |
| 2010 Q4 | 16.17 Million USD | -14.26% |
| 2010 Q1 | 21.58 Million USD | -66.99% |
| 2010 FY | 16.17 Million USD | -75.27% |
| 2010 Q2 | 19.54 Million USD | -9.45% |
| 2010 Q3 | 18.86 Million USD | -3.51% |
| 2009 FY | 65.39 Million USD | -21.19% |
| 2009 Q3 | 63.05 Million USD | -0.11% |
| 2009 Q4 | 65.39 Million USD | 3.7% |
| 2009 Q2 | 63.12 Million USD | 0.53% |
| 2009 Q1 | 62.79 Million USD | -24.33% |
| 2008 Q1 | 71.85 Million USD | 2.44% |
| 2008 FY | 82.97 Million USD | 18.3% |
| 2008 Q2 | 71.76 Million USD | -0.13% |
| 2008 Q4 | 82.97 Million USD | 17.92% |
| 2008 Q3 | 70.36 Million USD | -1.94% |
| 2007 Q2 | 69.85 Million USD | 1.15% |
| 2007 Q4 | 70.14 Million USD | 2.9% |
| 2007 FY | 70.14 Million USD | 808.09% |
| 2007 Q1 | 69.05 Million USD | 794.04% |
| 2007 Q3 | 68.16 Million USD | -2.41% |
| 2006 Q2 | 6.61 Million USD | -8.2% |
| 2006 Q3 | 9.19 Million USD | 38.93% |
| 2006 FY | 7.72 Million USD | 5.61% |
| 2006 Q4 | 7.72 Million USD | -15.95% |
| 2006 Q1 | 7.2 Million USD | -1.48% |
| 2005 Q3 | 3.16 Million USD | 4.82% |
| 2005 Q1 | 80.01 Million USD | 0.0% |
| 2005 Q2 | 3.01 Million USD | -96.23% |
| 2005 Q4 | 7.31 Million USD | 131.41% |
| 2005 FY | 7.31 Million USD | -90.7% |
| 2004 FY | 78.66 Million USD | 47.41% |
| 2003 FY | 53.36 Million USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -8086.483% |
| BrainsWay Ltd. | 15.31 Million USD | -27299.112% |
| Cerus Corporation | 144.3 Million USD | -2807.681% |
| Envoy Medical, Inc. | 9.4 Million USD | -44527.739% |
| electroCore, Inc. | 8.94 Million USD | -46807.77% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -78445.489% |
| IceCure Medical Ltd | 4.24 Million USD | -98696.798% |
| Inogen, Inc. | 121.38 Million USD | -3356.773% |
| OrthoPediatrics Corp. | 72.56 Million USD | -5682.583% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -14084.443% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -131765.97% |
| MaxCyte, Inc. | 36.1 Million USD | -11520.738% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -226961.924% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -986518.259% |
| Orthofix Medical Inc. | 326.58 Million USD | -1184.78% |
| PAVmed Inc | 57.13 Million USD | -7243.578% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -16378.42% |
| RxSight, Inc. | 22.18 Million USD | -18810.672% |
| Sight Sciences, Inc. | 46.43 Million USD | -8935.877% |
| SI-BONE, Inc. | 61.05 Million USD | -6772.891% |
| TELA Bio, Inc. | 59.16 Million USD | -6991.622% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -3581.615% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -40561.886% |
| Acutus Medical, Inc. | 54.83 Million USD | -7551.307% |
| Talis Biomedical Corporation | 29.22 Million USD | -14257.72% |
| Spectral AI, Inc. | 12.4 Million USD | -33735.175% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -18037.374% |
| CVRx, Inc. | 39.28 Million USD | -10581.483% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -34988.415% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -172620.537% |
| Bioventus Inc. | 589.79 Million USD | -611.42% |
| Venus Concept Inc. | 107.1 Million USD | -3817.631% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -8021.673% |
| LivaNova PLC | 1.15 Billion USD | -264.248% |
| 908 Devices Inc. | 37.49 Million USD | -11092.051% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -496.441% |
| Nemaura Medical Inc. | 26.37 Million USD | -15807.159% |
| NeuroPace, Inc. | 86.99 Million USD | -4723.04% |
| LENSAR, Inc. | 22.4 Million USD | -18624.173% |
| Apyx Medical Corporation | 52.31 Million USD | -7919.993% |
| Cutera, Inc. | 518.12 Million USD | -709.83% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -14206.806% |
| BioSig Technologies, Inc. | 4.68 Million USD | -89460.299% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -7088.822% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -19426.713% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | -91.235% |
| Axonics, Inc. | 82.35 Million USD | -4994.647% |
| Outset Medical, Inc. | 190.91 Million USD | -2097.784% |
| IRIDEX Corporation | 24.91 Million USD | -16741.535% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -3284.746% |
| IRadimed Corporation | 20.73 Million USD | -20134.922% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -250551.135% |
| INVO Bioscience, Inc. | 19.99 Million USD | -20884.786% |
| Telesis Bio, Inc. | 40.87 Million USD | -10165.701% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -10186.532% |
| Varex Imaging Corporation | 668.6 Million USD | -527.565% |
| Quipt Home Medical Corp. | 136.29 Million USD | -2978.588% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -117366.405% |
| Pulmonx Corporation | 60.63 Million USD | -6819.817% |
| Dynatronics Corporation | 11.78 Million USD | -35518.498% |
| Modular Medical, Inc. | 2.27 Million USD | -184578.697% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -103145.571% |
| Semler Scientific, Inc. | 6.27 Million USD | -66820.255% |
| InMode Ltd. | 75.91 Million USD | -5427.175% |
| Bruker Corporation | 2.83 Billion USD | -47.92% |
| Cytosorbents Corporation | 29.98 Million USD | -13893.11% |
| Align Technology, Inc. | 2.45 Billion USD | -71.025% |
| Viveve Medical, Inc. | 10.84 Million USD | -38582.585% |
| ZimVie Inc. | 795.85 Million USD | -427.221% |
| Movano Inc. | 5.97 Million USD | -70159.545% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -3911.185% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -986518.259% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -34988.415% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -556.609% |
| Profound Medical Corp. | 12.66 Million USD | -33027.626% |
| Insulet Corporation | 1.85 Billion USD | -126.133% |
| enVVeno Medical Corporation | 2.43 Million USD | -172216.222% |
| Surmodics, Inc. | 65.82 Million USD | -6274.52% |
| iCAD, Inc. | 8 Million USD | -52342.201% |
| Nuwellis, Inc. | 6.78 Million USD | -61786.431% |
| Biotricity, Inc. | 35.91 Million USD | -11581.418% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -1781.173% |
| Aethlon Medical, Inc. | 2.47 Million USD | -169113.397% |
| InspireMD, Inc. | 8.14 Million USD | -51434.027% |
| PAVmed Inc. | 57.13 Million USD | -7243.578% |
| BIOLASE, Inc. | 35.34 Million USD | -11770.261% |
| Beyond Air, Inc. | 29.77 Million USD | -13992.024% |
| FONAR Corporation | 57.45 Million USD | -7202.605% |
| AxoGen, Inc. | 101.16 Million USD | -4047.704% |
| Vivani Medical, Inc. | 25.03 Million USD | -16659.466% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -4679.147% |
| Inari Medical, Inc. | 209.32 Million USD | -1904.491% |
| UFP Technologies, Inc. | 118.04 Million USD | -3454.492% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -32963.331% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -191860.699% |
| Tenon Medical, Inc. | 5.56 Million USD | -75270.936% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -235757.223% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -23694.219% |
| AdaptHealth Corp. | 3.15 Billion USD | -33.07% |
| Sintx Technologies, Inc. | 6.59 Million USD | -63541.741% |
| NanoVibronix, Inc. | 2.68 Million USD | -156113.701% |
| Quanterix Corporation | 78.08 Million USD | -5273.572% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -117366.405% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -85793.552% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | -301.633% |
| TransMedics Group, Inc. | 568.84 Million USD | -637.617% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -25052.26% |
| NeuroMetrix, Inc. | 1.33 Million USD | -314641.914% |
| Hyperfine, Inc. | 9.8 Million USD | -42715.306% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -1576.71% |
| Biomerica, Inc. | 2.66 Million USD | -157462.899% |
| Bone Biologics Corporation | 831.4 Thousand USD | -504577.641% |
| AVITA Medical, Inc. | 19.86 Million USD | -21021.646% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -212492.397% |
| Silk Road Medical, Inc | 114.15 Million USD | -3575.52% |